Sequence ConfirmationConformation AnalysisDisulfide MappingOrthogonal Characterization
At Creative Peptides, we provide custom peptide structural analysis services for research and development teams that need more than a routine purity check. Our workflows are built to clarify peptide identity, solution conformation, structural heterogeneity, disulfide connectivity, and structure-related changes that can affect downstream interpretation. We support linear, cyclic, stapled, modified, and conjugated peptides by combining peptide analysis services, spectroscopy, LC-MS-based characterization, and data interpretation tailored to the actual technical question. Whether you are confirming a newly synthesized sequence, comparing analogs, troubleshooting unstable material, or connecting structural observations to follow-on structure-activity relationship (SAR) analysis, we help generate decision-supportive structural data for peptide programs.
Integrated peptide structural analysis workflow combining mass spectrometry, conformational spectroscopy, and data interpretation to resolve identity, conformation, and heterogeneity questionsMany peptide projects reach a point where the expected sequence alone is not enough to explain experimental behavior. A peptide may pass a simple mass check yet still show inconsistent assay performance, poor reproducibility, unexpected retention behavior, loss of activity after storage, or unclear differences between analogs. In these cases, the real issue is often structural rather than purely compositional.
Peptide structural analysis helps development and research teams answer the questions that most often slow projects down:
We design peptide structural analysis studies around the actual development question, not around a one-size-fits-all test menu. Projects can begin from a synthetic peptide, client-supplied material, a stressed or reformulated sample, or a comparative set of analogs. Where needed, structural work can be integrated with peptide sequence analysis, chemical & physical analyses, and follow-on optimization studies to help teams move from structural observation to practical next steps.
Effective peptide structural analysis starts with the right analytical question. We review sequence length, cyclization mode, modification pattern, expected structural complexity, sample state, and target readout before defining a fit-for-purpose workflow.
This front-end assessment helps reduce avoidable rework and improves alignment between sample behavior and method choice.
For projects that begin with a fundamental identity question, we support primary structure verification using LC-MS, LC-MS/MS, high-resolution mass analysis, and related workflows appropriate to peptide size and complexity.
These workflows are especially useful when a project needs to establish whether the observed material matches the intended design before deeper conformational analysis begins.
Peptides often show structure that is condition-dependent rather than fixed. We support secondary-structure-oriented studies that help teams understand whether a peptide is predominantly helical, sheet-forming, turn-rich, or conformationally disordered under selected solution conditions.
This service is valuable when teams need a practical readout of how peptide structure behaves in solution rather than a sequence-only answer.
When a project requires higher-resolution information, we provide NMR-oriented workflows to investigate peptide conformation, structural restraints, and solution-state behavior with greater depth.
NMR is particularly useful when atomic-level or near-atomic-level conformational insight is needed to clarify peptide behavior beyond chromatographic or mass-based data alone.
Connectivity questions are common in structurally constrained peptides, especially when cysteine pairing, ring closure, or orthogonal modification steps may generate closely related forms. We support targeted workflows to clarify these structural features.
This support helps clients determine whether a peptide's architecture matches the intended design and whether connectivity issues are driving inconsistent performance.
Not all structural problems present as a single unknown peak. Many arise from conformational heterogeneity, closely related impurities, or condition-dependent changes that are easy to overlook without a combined analytical strategy.
The goal is not simply to list differences, but to help clarify which differences matter and what to do next.
Peptide programs often need side-by-side structural comparison rather than isolated single-sample testing. We support structured comparison workflows for analog sets, formulation variants, process changes, and modified constructs.
These workflows are well suited to projects where structural evidence must directly support go/no-go or redesign decisions.
No single technique can answer every structural question. The most informative projects usually combine orthogonal methods so that identity, conformation, and heterogeneity are interpreted together rather than in isolation.
| Analytical Approach | Primary Structural Question | Typical Output | Best Used For | Key Consideration |
|---|---|---|---|---|
| LC-MS / HRMS | Does the observed peptide mass and major component match the intended construct? | Intact mass, peak distribution, related-species overview | Identity checks, modified peptide review, impurity screening | Mass agreement alone does not fully resolve same-mass isomers or conformational variants |
| LC-MS/MS Sequence Confirmation | Can the sequence or modification site be confirmed with fragment evidence? | Fragment ions, sequence coverage, site-supporting assignments | New constructs, unknowns, modified or conjugated peptides | Coverage depth depends on peptide length, fragmentation behavior, and sample quality |
| Circular Dichroism (CD) | What secondary-structure tendency does the peptide show in solution? | CD spectra, comparative secondary-structure estimates, condition-dependent shifts | Helicity review, buffer comparison, folding tendency screening | Best interpreted with careful control of solvent, concentration, and baseline conditions |
| NMR Spectroscopy | What is the peptide's solution-state conformation and restraint-supported structural behavior? | Chemical shifts, NOE information, conformational interpretation | Cyclic peptides, constrained peptides, deeper conformation studies | Sample amount, purity, and spectral complexity determine practical study depth |
| Reducing / Non-Reducing Mapping | Are disulfide bonds and connectivity consistent with the intended architecture? | Disulfide-linked species, free cysteine status, connectivity evidence | Disulfide-rich peptides, oxidation route assessment, constrained analogs | Disulfide scrambling and sample handling can affect interpretation if not controlled |
| Computational Structure Modeling | Which conformational hypotheses should be prioritized for experimental review? | Predicted structural models, comparative conformer hypotheses, visualization support | Analog triage, design support, structure-data integration | Prediction is most useful when treated as a hypothesis-building tool and checked against experimental data |
Structural analysis is most effective when the analytical plan matches the decision that the client needs to make. The table below shows how common project situations can be translated into practical workflows and actionable outputs.
| Project Situation | Typical Workflow | Useful Inputs | Representative Readouts | Decision Value |
|---|---|---|---|---|
| New Synthetic Peptide Verification | Intact mass confirmation plus MS/MS-supported sequence review | Expected sequence, modification details, theoretical mass, sample history | Identity confirmation, major impurity profile, sequence-supporting fragments | Confirms whether the material is suitable for downstream biological or formulation work |
| Cyclic or Disulfide-Rich Peptide Assessment | Connectivity-focused LC-MS strategy with complementary conformational analysis | Cyclization route, cysteine positions, oxidation conditions, reference expectations | Ring closure evidence, disulfide status, structure-related heterogeneity review | Helps determine whether architecture-related issues are limiting performance |
| Buffer or Formulation Comparison | CD-led comparison with orthogonal LC-MS checks before and after stress or storage | Buffer compositions, pH, storage conditions, concentration range | Conformational shifts, emerging degradants, comparative stability trends | Supports selection of better handling and formulation conditions |
| Analog Ranking and SAR Support | Cross-sample structural comparison using mass, conformation, and condition-response data | Analog sequences, design rationale, biological readouts, target structural concern | Structure-linked differences between analogs, modification tolerance, comparative profiles | Helps prioritize which analogs deserve synthesis scale-up or further optimization |
| Unknown Peak or Instability Investigation | Impurity/degradation study with targeted MS interpretation and condition comparison | Fresh versus aged samples, chromatograms, observed failure mode, storage history | Assignment of major unknowns where feasible, degradation trend, likely structural cause | Helps distinguish whether the next step should be resynthesis, reformulation, or redesign |
| Model Validation or Structural Hypothesis Testing | Experimental verification of predicted structural tendencies using orthogonal readouts | Predicted model, key residues, design objectives, target conditions | Agreement or mismatch between predicted and observed structural behavior | Reduces overreliance on sequence-based or in silico assumptions |
Orthogonal Evidence Design
We combine complementary methods so that sequence, conformation, and heterogeneity are interpreted together instead of relying on a single data point.
Peptide-Specific Method Selection
Study plans are matched to peptide size, constraint type, modification pattern, and sample behavior rather than using a fixed analytical package.
Stronger Resolution of Complex Samples
Our workflows are designed to clarify closely related species, disulfide variants, and structure-linked impurities that routine checks may miss.
Structure-to-Decision Interpretation
We focus on what the structural data means for next actions such as resynthesis, reformulation, analog selection, or deeper investigation.
Coverage for Challenging Peptide Formats
Linear, cyclic, stapled, labeled, conjugated, and disulfide-rich peptides can require different structural strategies, and we plan accordingly.
Clear Reporting for Cross-Functional Teams
Final outputs are organized to support chemistry, biology, formulation, and external collaboration teams working from the same project data.
Our workflow is designed to move from the client's structural question to an interpretable data package that supports practical project decisions.
1
Technical Intake and Objective Definition
2
Sample Review and Feasibility Assessment
3
Orthogonal Analytical Plan Setup
4
Data Acquisition and Comparative Review
5
Interpretation and Structural Conclusion
6
Reporting and Follow-On Recommendations
Peptide structural analysis supports projects wherever a sequence-level answer is not sufficient. Below are representative areas where structure-focused characterization provides clear technical value.
It can help confirm sequence-supported identity, secondary-structure tendency, solution conformation, disulfide connectivity, structural heterogeneity, and whether formulation or modification has changed peptide behavior.
Common approaches include LC-MS or HRMS for identity and impurity review, LC-MS/MS for sequence confirmation, CD for secondary-structure trends, and NMR for deeper solution-state conformational analysis.
Yes. These formats often require tailored workflows focused on cyclization status, disulfide pairing, conformational constraint, and closely related structural variants.
This usually requires orthogonal analysis rather than a single mass result. Comparative chromatography, MS/MS fragmentation, connectivity-focused testing, and conformational data can help clarify structurally similar species.
The most useful inputs are the expected sequence, modification or cyclization details, theoretical mass, sample amount, solvent or buffer information, purity expectations, and the specific structural question you need answered.
If your team needs a reliable partner for peptide structural analysis, Creative Peptides can support your project with fit-for-purpose method selection, orthogonal characterization, and practical interpretation of sequence and conformation data. We work with research teams on custom studies covering identity confirmation, disulfide mapping, comparative conformation analysis, impurity investigation, and structure-linked troubleshooting. Contact us today to discuss your peptide sequence, sample status, and analytical goals.
